In recent years, the therapeutic footprint of this class has grown: long-acting agents (e.g., liraglutide, semaglutide) and next-generation dual/triple agonists (e.g., tirzepatide) have demonstrated superior glycemic control, weight reduction, and cardiovascular benefits in adults with T2DM (Yao et al., 2024)
Shravya G, specializes in cosmetic dermatology and has been invited to prestigious international workshops
While also not prescribing GLP-1s personally, Brandon Peters, MD, FAASM, a sleep physician at Virginia Mason Medical Center, has patients taking GLP-1s for obesity or diabetes and seeing improvements in their OSA
By increasing glucose uptake in muscle cells, IGF-1 helps lower blood glucose levels, thereby reducing the need for insulin secretion (Clemmons, 2004)
Animal studies suggest that it doesnt raise levels of cortisol or prolactintwo other hormones that can have a negative impact on body composition